The Potential Threat to Blood Transfusion Safety of Emerging Infectious Disease Agents

Clinical Advances in Hematology & Oncology July 2015, Volume 13, Issue 7 Susan L. Stramer, PhD Vice President, Scientific Affairs American Red Cross Gaithersburg, Maryland […]

The New Paradigm for Transfusion of Platelets

Clinical Advances in Hematology & Oncology May 2015, Volume 13, Issue 5 Richard M. Kaufman, MD Medical Director, Adult Transfusion Service, Brigham and Women’s Hospital, Assistant Professor […]

The Shifting Paradigm for Transfusion of Red Blood Cells

Clinical Advances in Hematology & Oncology March 2015, Volume 13, Issue 3 Jeffrey L. Carson, MD, Richard C. Reynolds Professor of Medicine, Chief, Division of General Internal Medicine, Rutgers Robert […]

Understanding Bleeding in Ebola Virus Disease

Clinical Advances in Hematology & Oncology January 2015, Volume 13, Issue 1 Anita McElroy, MD, PhD, Assistant Professor, Infectious Diseases, Department of Pediatrics, Emory University School of Medicine, Atlanta, Georgia H&O […]

Blood Component Support in Patients With Solid Tumors and Hematologic Malignancies: Lessons From the Treatment of Jehovah’s Witnesses

Clinical Advances in Hematology & Oncology December 2014, Volume 12, Issue 12 Kaaron Benson, MD, Medical Director, Blood Bank/HLA Laboratory, Moffitt Cancer Center, Tampa, Florida H&O When are blood […]

Thrombosis and Thrombophilia in Children

Clinical Advances in Hematology & Oncology November 2014, Volume 12, Issue 11 Neil Goldenberg, MD, PhD, Associate Professor of Pediatrics, Johns Hopkins University School of Medicine, Baltimore, Maryland, Director […]

The Red Cell Membrane, Part 3: The Role of the Red Cell Membrane in Coagulation and Hypercoagulability

Clinical Advances in Hematology & Oncology October 2014, Volume 12, Issue 10 Bas De Laat, PhD Associate Professor, Department of Biochemistry, Maastricht University, Maastricht, the Netherlands This is […]

The Red Cell Membrane, Part 2: Disorders of the Red Cell Membrane

Clinical Advances in Hematology & Oncology September 2014, Volume 12, Issue 9 Xiuli An, MD, PhD, Associate Member, New York Blood Center, New York, NY This is part […]

The Red Cell Membrane, Part 1: The Role of the Red Cell Membrane

Clinical Advances in Hematology & Oncology August 2014, Volume 12, Issue 8 Sant-Rayn Pasricha, MBBS, MPH, PhD, FRACP, FRCPA, NHMRC CJ Martin Early Career Fellow, MRC Weatherall Institute […]

Understanding Congenital Platelet Disorders

July 2014, Volume 12, Issue 7 Jorge Di Paola, MD Associate Professor of Pediatrics and Genetics University of Colorado Anschutz Medical Campus, Aurora, Colorado H&O What are congenital […]

Advances in the Management of ITP in Children and Adults

Clinical Advances in Hematology & Oncology June 2014, Volume 12, Issue 6 Paul Imbach, MD, Intercontinental Cooperative ITP Study Group Chairperson, Hematology/Oncology Unit, University Children’s Hospital, Basel, Switzerland H&O What is […]

A New Era of Therapy for Congenital Factor XIII Deficiency

Clinical Advances in Hematology & Oncology May 2014, Volume 12, Issue 5 Manuel Carcao, MD Associate Professor of Pediatrics University of Toronto Toronto, Ontario, Canada H&O […]

Atypical Hemolytic Uremic Syndrome: The Role of Complement Pathway Gene Mutation Analysis

Clinical Advances in Hematology & Oncology April 2014, Volume 12, Issue 4 Ilene C. Weitz, MD Associate Professor of Clinical Medicine, Jane Anne Nohl Division of Hematology, Keck School […]

Iron Chelation for Iron Overload Secondary to Transfusions of Packed Red Blood Cells

Clinical Advances in Hematology & Oncology March 2014, Volume 12, Issue 3 Joan Cid, MD Senior Specialist, Apheresis Unit, Department of Hemotherapy and Hemostasis, Hospital Clinic, IDIBAPS, Barcelona, Spain H&O Could […]

Diagnosis of von Willebrand Disease in People With Type O Blood

Clinical Advances in Hematology & Oncology February 2014, Volume 12, Issue 2 Diagnosis of von Willebrand Disease in People With Type O Blood Joan Cox Gill, […]

Update on the Diagnosis and Management of Thalassemia

Clinical Advances in Hematology & Oncology January 2014, Volume 12, Issue 1 Mitchell J. Weiss, MD, PhD Jane Fishman Grinberg Professor of Pediatrics Division of Hematology The […]

New Antiplatelet Agents: Are We Better Off Now Than We Were With Aspirin?

Clinical Advances in Hematology & Oncology December 2013, Volume 11, Issue 12 New Antiplatelet Agents: Are We Better Off Now Than We Were With Aspirin? Sergio Coccheri, […]

Sickle Cell Disease: New Treatments and Their Rationale

Clinical Advances in Hematology & Oncology November 2013, Volume 11, Issue 11 ADVANCES IN HEMATOLOGY Sickle Cell Disease: New Treatments and Their Rationale Joshua J. Field, MD […]

Hemolytic Disease of the Fetus and Newborn

Clinical Advances in Hematology & Oncology October 2013, Volume 11, Issue 10 Kenneth J. Moise, Jr, MD Codirector, Texas Fetal Center Children’s Memorial Hermann Hospital Visiting Professor […]

The Effects of Cardiopulmonary Bypass on Coagulation

Clinical Advances in Hematology & Oncology September 2013, Volume 11, Issue 9 Jerrold H. Levy, MD Professor of Anesthesiology Associate Professor of Surgery Codirector, Cardiothoracic […]